Preclinical investigation of orally bioavailable, potent KRASMulti inhibitor JAB-23425

被引：0
|
作者：
Wang, Peng
Wang, Yanping
Sun, Xin
Liu, Dan
Liu, Xiaoyu
Zhang, Wei
He, Xueting
Zhou, Rui
Ma, Cunbo
Li, Amin
Lin, Yiwei
Long, Wei
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1660
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor
    Martinez Gonzalez, Sonia
    Isabel Hernandez, Ana
    Varela, Carmen
    Rodriguez-Aristegui, Sonsoles
    Lorenzo, Milagros
    Rodriguez, Antonio
    Rivero, Virginia
    Ignacio Martin, Jose
    Gustav Saluste, Carl
    Ramos-Lima, Francisco
    Cendon, Elena
    Cebrian, David
    Aguirre, Enara
    Gomez-Casero, Elena
    Albarran, Maribel
    Alfonso, Patricia
    Garcia-Serelde, Beatriz
    Oyarzabal, Julen
    Rabal, Obdulia
    Mulero, Francisca
    Gonzalez-Granda, Teresa
    Link, Wolfgang
    Fominaya, Jesus
    Barbacid, Mariano
    Bischoff, James R.
    Pizcueta, Pilar
    Pastor, Joaquin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (10) : 3460 - 3466
  • [42] Discovery of WX486 as a novel, potent, selective, and orally bioavailable irreversible inhibitor of BTK
    Wu, Chengde
    Shen, Chunli
    Zhu, Yuchuan
    Hu, Guoping
    Lin, Jian
    Chen, Shuhui
    Xiao, Qiang
    Huang, Lu
    Chen, Hailiang
    Tu, Ronghua
    Xu, Yong
    Wang, Xuehai
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [43] From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors
    Koravovic, Mladen
    Mayasundari, Anand
    Tasic, Gordana
    Keramatnia, Fatemeh
    Stachowski, Timothy R.
    Cui, Huarui
    Chai, Sergio C.
    Jonchere, Barbara
    Yang, Lei
    Li, Yong
    Fu, Xiang
    Hiltenbrand, Ryan
    Paul, Leena
    Mishra, Vibhor
    Klco, Jeffery M.
    Roussel, Martine F.
    Pomerantz, William CK.
    Fischer, Marcus
    Rankovic, Zoran
    Savic, Vladimir
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 251
  • [44] Characterization of a Potent and Orally Bioavailable Lys-Covalent Inhibitor of Apoptosis Protein (IAP) Antagonist
    Udompholkul, Parima
    Garza-Granados, Ana
    Alboreggia, Giulia
    Baggio, Carlo
    McGuire, Jack
    Pegan, Scott D. D.
    Pellecchia, Maurizio
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 8159 - 8169
  • [45] Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
    Zheng, Xiufang
    Gao, Lu
    Wang, Lisha
    Liang, Chungen
    Wang, Baoxia
    Liu, Yongfu
    Feng, Song
    Zhang, Bo
    Zhou, Mingwei
    Yu, Xin
    Xiang, Kunlun
    Chen, Li
    Guo, Tao
    Shen, Hong C.
    Zou, Gang
    Wu, Jim Zhen
    Yun, Hongying
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6003 - 6014
  • [46] Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1
    Dow, Robert L.
    Li, Jian-Cheng
    Pence, Michael P.
    Gibbs, E. Michael
    LaPerle, Jennifer L.
    Litchfield, John
    Piotrowski, David W.
    Munchhof, Michael J.
    Manion, Tara B.
    Zavadoski, William J.
    Walker, Gregory S.
    McPherson, R. Kirk
    Tapley, Susan
    Sugarman, Eliot
    Guzman-Perez, Angel
    DaSilva-Jardine, Paul
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (05): : 407 - 412
  • [47] IPI-493, a potent, orally bioavailable Hsp90 inhibitor of the ansamycin class
    Lee, J.
    Grenier, L.
    Holson, E.
    Slocum, K.
    Gel, J.
    Normant, E.
    Hoyt, J.
    Cushing, J.
    Sydor, J.
    Wright, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 49 - 49
  • [48] Discovery and characterization of QTX3034, a potent, selective, and orally bioavailable allosteric KRAS inhibitor
    Zhang, Yang W.
    Rominger, Dave
    Vo, Elizabeth Donohue
    Silva, Jillian M.
    Zhang, Yang J.
    Lee, Greg
    Micozzi, John
    Reid, Ben
    McDonough, Brooke
    Hospital, Audrey
    Luengo, Juan I.
    Pitt, Cameron
    Lin, Hong
    CANCER RESEARCH, 2023, 83 (08)
  • [49] L735,524 - THE RATIONAL DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR
    DORSEY, BD
    LEVIN, RB
    MCDANIEL, SL
    VACCA, JP
    DARKE, PL
    ZUGAY, JA
    EMINI, EA
    SCHLEIF, WA
    QUINTERO, JC
    LIN, JH
    CHEN, IW
    OSTOVIC, D
    FITZGERALD, PMD
    HOLLOWAY, MK
    ANDERSON, PS
    HUFF, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 6 - MEDI
  • [50] Discovery of ITX 4520: A highly potent orally bioavailable hepatitis C virus entry inhibitor
    Mittapalli, Gopi Kumar
    Zhao, Fang
    Jackson, Andrew
    Gao, Hongfeng
    Lee, Haekyung
    Chow, Stephine
    Kaur, Maninder Pal
    Natalie Nguyen
    Zamboni, Robert
    McKelvy, Jeffrey
    Wong-Staal, Flossie
    Macdonald, James E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4955 - 4961
12345